Insights

Loading spinner
Gathering insights about Valerio Therapeutics

Similar companies to Valerio Therapeutics

Valerio Therapeutics Tech Stack

Valerio Therapeutics uses 8 technology products and services including Site Kit, WordPress, Open Graph, and more. Explore Valerio Therapeutics's tech stack below.

  • Site Kit
    Analytics
  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • MySQL
    Database
  • Select2
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • PHP
    Programming Languages
  • SiteOrigin Page Builder
    Web Platform Extensions

Valerio Therapeutics's Email Address Formats

Valerio Therapeutics uses at least 2 format(s):
Valerio Therapeutics Email FormatsExamplePercentage
F.Last@onxeo.comJ.Doe@onxeo.com
87%
First.Last@onxeo.comJohn.Doe@onxeo.com
8%
Last@onxeo.comDoe@onxeo.com
5%

Frequently Asked Questions

Where is Valerio Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Valerio Therapeutics's main headquarters is located at 49 Boulevard du Général Martial Valin Paris, 75015 FR. The company has employees across 2 continents, including EuropeNorth America.

What is Valerio Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Valerio Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Valerio Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Valerio Therapeutics's official website is valeriotx.com and has social profiles on LinkedIn.

How much revenue does Valerio Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Valerio Therapeutics's annual revenue reached $7.5M.

What is Valerio Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Valerio Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Valerio Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Valerio Therapeutics has approximately 64 employees across 2 continents, including EuropeNorth America. Key team members include Chief Regulatory Officer: H. J.Vice President - Discovery And Preclinical: W. J.Head Of Quality Assurance: C. C.. Explore Valerio Therapeutics's employee directory with LeadIQ.

What industry does Valerio Therapeutics belong to?

Minus sign iconPlus sign icon
Valerio Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Valerio Therapeutics use?

Minus sign iconPlus sign icon
Valerio Therapeutics's tech stack includes Site KitWordPressOpen GraphMySQLSelect2ModernizrPHPSiteOrigin Page Builder.

What is Valerio Therapeutics's email format?

Minus sign iconPlus sign icon
Valerio Therapeutics's email format typically follows the pattern of . Find more Valerio Therapeutics email formats with LeadIQ.

When was Valerio Therapeutics founded?

Minus sign iconPlus sign icon
Valerio Therapeutics was founded in 2014.
Valerio Therapeutics

Valerio Therapeutics

Pharmaceutical ManufacturingParis, France51-200 Employees

Valerio Therapeutics is a clinical-stage biotechnology company based in France and the US that develops new drugs by targeting tumor DNA functions through unique mechanisms of action in the field of DNA Damage Response (DDR). 

DDR consists of a network of cellular pathways that detect, report and repair DNA damage. Applied to oncology, this new field of research aims to weaken or block the ability of tumor cells to repair damage to their DNA, either naturally or under the effect of cytotoxic treatments. 

Focusing exclusively on intracellular DNA-binding targets, we design and develop first-in-class treatments for oncology and inflammatory diseases precision therapeutics from preclinical (translational) research to human clinical proof-of-concept studies. It thus leads its programs to the most value-creating and attractive inflection points for potential partners.

The Company's portfolio is based on platON™, Valerio Therapeutic's decoy oligonucleotide platform. 

PlatON™ is intended to generate new compounds based on an unparalleled DDR decoy mechanism and capitalizing on the expertise the Company has developed on this type of oligonucleotides. 

The Company's portfolio includes: 
-	AsiDNA™, a first-in-class product interfering with tumor DNA break repair, based on a decoy agonist mechanism, unmatched in the DDR field, which could, among other things, combat tumor resistance. AsiDNA™ is in clinical development in several trials, in combination with PARP inhibitors or in combination with radiation therapy. 
-	A new family of compounds are positioned as a new-generation PARP agonists that are designed not to induce resistance and to activate the immune response. VIO-01, is currently being optimized in a preclinical phase.

The Company is convinced of the significant therapeutic potential of its technology and the disruptive innovation it represents, which could pave the way for a new paradigm in cancer and inflammatory disease treatments.

Section iconCompany Overview

Headquarters
49 Boulevard du Général Martial Valin Paris, 75015 FR
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $10M

    Valerio Therapeutics's revenue is in the range of $10M

Section iconFunding & Financials

  • $10M

    Valerio Therapeutics's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.